Internal Medicine, Nephrology · Northport, AL
NPI
1144295221
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
4400 Watermelon Rd Ste B
Northport, AL, 35473
Phone (205) 345-6302
Groups this clinician bills Medicare through
Medicare paid, 2024
$322K
6,025 services
Medicare patients, 2024
527
Average age 74
Drug cost, 2024
$721K
2,587 prescriptions
Company payments, 2025
$1,584
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey N Alilonu was code 99232 (hospital e&m - subsequent), 1,168 times for 248 patients. In total Geoffrey N Alilonu billed 6,025 services in 26 codes, and Medicare paid $322K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,168 | 248 | $53.86 | $63K |
| 90935 Hemodialysis | Facility | 461 | 81 | $48.58 | $22K |
| 90960 ESRD Related Services (not dialysis) | Office | 433 | 57 | $241.21 | $104K |
| 85018 Blood Count | Office | 306 | 188 | $2.32 | $710 |
| 85014 Blood Count | Office | 305 | 187 | $2.32 | $708 |
| 83970 Clinical Chemistry | Office | 305 | 187 | $40.45 | $12K |
| 80048 Clinical Chemistry | Office | 297 | 183 | $8.29 | $2,462 |
| 84100 Clinical Chemistry | Office | 296 | 183 | $4.65 | $1,376 |
| 81002 Clinical Chemistry | Office | 294 | 179 | $3.41 | $1,003 |
| 82570 Clinical Chemistry | Office | 281 | 177 | $5.08 | $1,427 |
| 82043 Clinical Chemistry | Office | 279 | 177 | $5.66 | $1,579 |
| 36415 Venipuncture Blood Collection | Office | 277 | 181 | $6.86 | $1,900 |
| 82306 Clinical Chemistry | Office | 262 | 171 | $29.01 | $7,601 |
| 99223 Hospital E&M - Initial | Facility | 254 | 168 | $117.96 | $30K |
| 90945 Peritoneal Dialysis | Facility | 237 | 28 | $58.17 | $14K |
By year: 2022 $529K for 8,699 services; 2023 $445K for 7,236 services; 2024 $322K for 6,025 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85018 Blood Count | 306 | 188 | $2.32 | $710 |
| 83970 Clinical Chemistry | 305 | 187 | $40.45 | $12K |
| 85014 Blood Count | 305 | 187 | $2.32 | $708 |
| 80048 Clinical Chemistry | 297 | 183 | $8.29 | $2,462 |
| 84100 Clinical Chemistry | 296 | 183 | $4.65 | $1,376 |
| 81002 Clinical Chemistry | 294 | 179 | $3.41 | $1,003 |
| 82570 Clinical Chemistry | 281 | 177 | $5.08 | $1,427 |
| 82043 Clinical Chemistry | 279 | 177 | $5.66 | $1,579 |
| 36415 Venipuncture Blood Collection | 277 | 181 | $6.86 | $1,900 |
| 82306 Clinical Chemistry | 262 | 171 | $29.01 | $7,601 |
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey N Alilonu prescribed most often to Medicare patients was Losartan Potassium, with 315 prescriptions and refills. In total Geoffrey N Alilonu wrote 2,587 Medicare prescriptions that cost $721K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 315 | 556 | 91 | $2,108 |
| Rayaldee Calcifediol | 218 | 235 | 30 | $315K |
| Paricalcitol Generic | 204 | 267 | 40 | $26K |
| Sevelamer Carbonate Generic | 173 | 219 | 58 | $23K |
| Furosemide Generic | 142 | 258 | 46 | $792 |
| Lisinopril Generic | 134 | 203 | 31 | $729 |
| Farxiga Dapagliflozin Propanediol | 132 | 182 | 31 | $96K |
| Amlodipine Besylate Generic | 81 | 151 | 25 | $310 |
| Allopurinol Generic | 55 | 127 | 16 | $458 |
| Gentamicin Sulfate Generic | 53 | 53 | 16 | $1,619 |
| Jardiance Empagliflozin | 49 | 51 | Under 11 | $28K |
| Prosol Parenteral Amino Acid 20% No.1 | 46 | 46 | Under 11 | $13K |
| Cinacalcet Hcl Generic | 45 | 55 | Under 11 | $2,711 |
| Carvedilol Generic | 42 | 72 | 13 | $368 |
| Lokelma Sodium Zirconium Cyclosilicate | 39 | 42 | Under 11 | $30K |
Brand drugs: - claims; generic drugs: 1,956 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey N Alilonu $1,584 ($1,584 in general payments such as food, travel and fees) from 14 companies. The largest payer was Fresenius USA Marketing, Inc. with $336.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 29 | $336 |
| Amgen Inc. AMGN | 9 | $219 |
| OPKO Pharmaceuticals, LLC | 21 | $207 |
| Akebia Therapeutics Inc AKBA | 8 | $201 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $174 |
| Novo Nordisk Inc NVO | 12 | $158 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $93.19 |
| Calliditas Therapeutics US Inc. | 2 | $56.61 |
| GlaxoSmithKline, LLC. GSK | 2 | $34.52 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $27.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.